6 results
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... Potential Treatment ... Agents for Treatment ... Pharmacology #Management #CDiff
Treatment of Stable Wide-Complex Tachycardia
Regular
 • If ventricular tachycardia or uncertain rhythm:
    -
Treatment of Stable ... Avoid AV nodal agents ... irregular protocol #Stable ... #Tachycardia #Treatment ... management #cardiology #algorithm
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Treatment of Stable ... nodal blocking agents ... underlying cause #Stable ... #Tachycardia #Treatment ... management #cardiology #algorithm
IDSA Algorithm for the Management of Purulent skin and soft tissue infections (SSTIs). 
Mild infection: for
IDSA Algorithm for ... erysipelas with no focus ... oral antibiotic treatment ... Two newer agents ... #SSTIs #Algorithm
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
Potential Treatment ... Agents for Treatment ... × 10 days #CDiff ... ClostridiumDifficile #options #treatment ... pharmacology #idsa #table
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
of antifungal agents ... effects in the treatment ... penetration • Variable bioavailability ... valleyfever #management #treatment ... antifungals #comparison #table